Publications by authors named "Karsten Bjerre"

Claim this Profile
C
Correlation of High Seawater Temperature with Vibrio and Shewanella Infections, Denmark, 2010-2018.
Yaovi Mahuton Gildas Hounmanou, Jørgen Engberg, Karsten Dalsgaard Bjerre, Hanne Marie Holt, Bente Olesen

Emerg Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Nationwide Observational Study of Chlamydia trachomatis Infections in Denmark during the COVID-19 Pandemic.
Paula L Hedley, Steen Hoffmann, Ulrik Lausten-Thomsen, Marianne Voldstedlund, Karsten Dalsgaard Bjerre

Acta Derm Venereol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study.
Lene Wulff Krogsgaard, Ida Glode Helmuth, Bodil Hammer Bech, Oleguer Plana-Ripoll, Tina Hovgaard Lützen, Karsten Dalsgaard Bjerre

Vaccine· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of margin width in breast-conserving treatment of early breast cancer.
Anne Bodilsen, Karsten Bjerre, Birgitte V Offersen, Pernille Vahl, Nikolaj Amby

J Surg Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study.
Anne Bodilsen, Karsten Bjerre, Birgitte V Offersen, Pernille Vahl, Bent Ejlertsen

Ann Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.
Charlotte L T Jørgensen, Torsten O Nielsen, Karsten D Bjerre, Shuzhen Liu, Brett Wallden

Acta Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
Charlotte Levin Tykjær Jørgensen, Christina Bjerre, Bent Ejlertsen, Karsten D Bjerre, Eva Balslev

BMC Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.
Charlotte L T Jørgensen, Bent Ejlertsen, Karsten D Bjerre, Eva Balslev, Dorte L Nielsen

BMC Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer.
Christina Bjerre, Ann Knoop, Karsten Bjerre, Mathilde S Larsen, Katrine L Henriksen

Acta Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer survival and season of surgery: an ecological open cohort study.
Dorthe Teilum, Karsten D Bjerre, Anne M Tjønneland, Niels Kroman

BMJ Open· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy.
Mathilde S Larsen, Karsten Bjerre, Anne E Lykkesfeldt, Anita Giobbie-Hurder, Anne-Vibeke Laenkholm

Breast· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.
Mathilde S Larsen, Karsten Bjerre, Anita Giobbie-Hurder, Anne-Vibeke Lænkholm, Katrine L Henriksen

Acta Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.
Dorte Lisbet Nielsen, Karsten D Bjerre, Erik H Jakobsen, Søren Cold, Lars Stenbygaard

J Clin Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Peer Christiansen, Karsten Bjerre, Bent Ejlertsen, Maj-Britt Jensen, Birgitte B Rasmussen

J Natl Cancer Inst· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1.
Per Edlund, Johan Ahlgren, Karsten Bjerre, Michael Andersson, Jonas Bergh

Acta Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.
Michael Andersson, Elisabeth Lidbrink, Karsten Bjerre, Erik Wist, Kristin Enevoldsen

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study.
Mikkel Rosendahl, Johan Ahlgren, Jørn Andersen, Jonas Bergh, Carl Blomquist, Karsten Bjerre

Eur J Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.
Susanne Møller, Maj-Britt Jensen, Bent Ejlertsen, Karsten D Bjerre, Martin Larsen

Acta Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry.
Henning T Mouridsen, Karsten D Bjerre, Peer Christiansen, Maj-Britt Jensen, Susanne Møller

Acta Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence pattern and prognosis in low-risk breast cancer patients--data from the DBCG 89-A programme.
Peer Christiansen, Nidal Al-Suliman, Karsten Bjerre, Susanne Møller,

Acta Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group's register 1978-2006.
Henrik W Kiaer, Anne-Vibeke Laenkholm, Bernt B Nielsen, Karsten D Bjerre

Acta Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis